{"id":"W2040176056","doi":"10.1007/s00280-009-1041-6","title":"A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation","year":2009,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Lapatinib; Pharmacokinetics; Medicine; Toxicity; Pharmacology; Gastroenterology; Phases of clinical research; Internal medicine; Oral administration; Cancer; Breast cancer; Trastuzumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00225962,0.001942055,0.0031237,0.0006312314,0.0003805653,0.001061778,0.0008493318,0.00128455,0.002491821],"category_scores_gemma":[0.001229738,0.0005794775,0.001728848,0.0006640678,0.001511847,0.001323173,0.0005358658,0.003128026,0.0008881955],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001358596,"about_ca_system_score_gemma":0.001884633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001578016,"about_ca_topic_score_gemma":0.003392857,"domain_scores_codex":[0.999308,0.0003231849,0.00003226917,0.0001172382,0.00005070363,0.0001685283],"domain_scores_gemma":[0.9990817,0.0001305234,0.0001744191,0.0001004277,0.00004937937,0.0004635346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8386862,0.03027401,0.008872303,0.0004037635,0.001815296,0.0002836075,0.0001996005,0.002379734,0.03099159,0.0003580916,0.004272545,0.08146334],"study_design_scores_gemma":[0.6690417,0.3071044,0.01392494,0.00002281868,0.000826953,0.000412226,0.00008929571,0.001826301,0.00462629,0.000474111,0.001588537,0.000062377],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956799,0.0009966625,0.0003851075,0.0004963545,0.00008222042,0.0006694027,0.0007772089,0.00007690187,0.0008362599],"genre_scores_gemma":[0.9909395,0.001177063,0.001183722,0.0009173903,0.0001550664,0.001023508,0.002731398,0.00004713765,0.00182513],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0031237,"threshold_uncertainty_score":0.01195019,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02916190242965619,"score_gpt":0.4183574430505823,"score_spread":0.389195540620926,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}